What is he best known for?
The fields of study he is best known for:
His main research concerns Immunology, Paroxysmal nocturnal hemoglobinuria, Molecular biology, Internal medicine and Gene.
His Immunology research incorporates elements of Stem cell and Cell biology.
His Paroxysmal nocturnal hemoglobinuria study combines topics from a wide range of disciplines, such as Hemoglobinuria, Bone marrow failure, Phenotype, CD59 and Clone.
His research in Molecular biology intersects with topics in Cell culture, Transfection, Mutation, Transcription factor and Conserved sequence.
His Internal medicine research incorporates themes from Gastroenterology and Endocrinology.
His Gene research is classified as research in Genetics.
His most cited work include:
- The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (845 citations)
- Natural history of paroxysmal nocturnal hemoglobinuria. (648 citations)
- Diagnosis and management of paroxysmal nocturnal hemoglobinuria. (555 citations)
What are the main themes of his work throughout his whole career to date?
Lucio Luzzatto mainly focuses on Immunology, Molecular biology, Genetics, Paroxysmal nocturnal hemoglobinuria and Gene.
The concepts of his Immunology study are interwoven with issues in Haematopoiesis, Bone marrow failure, Stem cell and Clone.
Lucio Luzzatto has included themes like T cell, T-cell receptor, Biochemistry, Coding region and Antibody in his Molecular biology study.
His study ties his expertise on Glucose-6-phosphate dehydrogenase together with the subject of Genetics.
His study looks at the intersection of Paroxysmal nocturnal hemoglobinuria and topics like Eculizumab with Complement inhibitor.
The study incorporates disciplines such as Gastroenterology and Endocrinology in addition to Internal medicine.
He most often published in these fields:
- Immunology (27.94%)
- Molecular biology (25.71%)
- Genetics (20.95%)
What were the highlights of his more recent work (between 2010-2021)?
- Immunology (27.94%)
- Malaria (8.89%)
- Paroxysmal nocturnal hemoglobinuria (20.00%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Immunology, Malaria, Paroxysmal nocturnal hemoglobinuria, Internal medicine and Eculizumab.
His Immunology research is multidisciplinary, incorporating elements of Clone, Haematopoiesis, Stem cell and Germline mutation.
His work in Malaria covers topics such as Pediatrics which are related to areas like Anemia.
His Paroxysmal nocturnal hemoglobinuria research integrates issues from Alternative complement pathway, Hemoglobinuria, Thrombosis, Surgery and Idiopathic aplastic anemia.
His Internal medicine research includes themes of Endocrinology and Glucose-6-phosphate dehydrogenase.
In his study, Genotype is inextricably linked to Complement receptor 1, which falls within the broad field of Eculizumab.
Between 2010 and 2021, his most popular works were:
- Glucose-6-Phosphate Dehydrogenase Deficiency (182 citations)
- G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications (114 citations)
- Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common (92 citations)
In his most recent research, the most cited papers focused on:
His primary areas of study are Immunology, Internal medicine, Endocrinology, Malaria and Primaquine.
His Immunology research is multidisciplinary, relying on both Haematopoiesis, Bone marrow failure and Pharmacogenetics.
His study focuses on the intersection of Haematopoiesis and fields such as Clone with connections in the field of Germline mutation.
As a member of one scientific family, he mostly works in the field of Internal medicine, focusing on Glucose-6-phosphate dehydrogenase and, on occasion, Hemoglobin.
The Endocrinology study combines topics in areas such as Paroxysmal nocturnal hemoglobinuria, Hemolysis, Molecular biology and Alternative complement pathway.
As a part of the same scientific study, Lucio Luzzatto usually deals with the Malaria, concentrating on Haemolysis and frequently concerns with Drug.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
